Skip to main content
. 2017 May 11;8(29):47780–47789. doi: 10.18632/oncotarget.17822

Table 3. Univariate analysis of b-EBV DNA and outcome variables (DFS, OS).

EBV DNAa DFS(median) P valueb OS(median) P valueb
4 Groups
 UQ 13 13
 Neg 62 0.0001 62 0.0001
 Q 27 31
 Q+ 33.5 37.5
3 Groups
 UQ, Q 23 26
 Q+ 33.5 0.0001 37.5 0.0002
 Neg 62 62

a EBV DNA was stratified into 4 and 3 groups: Neg, Negative (EBV DNA = 0); UQ, Positive but UnQuantifiable (0 < EBV DNA < 102 copies/mL); Q, Positive and quantifiable (102 ≤ EBV DNA ≤ 15 × 102 copies/mL); Q+, Strongly positive and quantifiable (EBV DNA > 15 × 102 copies/mL).

b The categorical variables were assessed using non-parametric Kruskal Wallis ANOVA. Statistically significant P values (P<0.05) are highlighted.